Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioning.
Saved in:
| Title: | Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioning. |
|---|---|
| Authors: | Jubas S; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Collins K; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Obara K; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Liu HH; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Kemper RM; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Kelley ALW; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Goel A; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Dunlap TC; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; Metrum Research Group, Boston, MA., Zhu J; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Randolph RM; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC., Ptachcinski JR; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC; Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; UNC Transplant and Cellular Therapy Program, University of North Carolina Medical Center, Chapel Hill, NC., Bizzell ME; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC; UNC Transplant and Cellular Therapy Program, University of North Carolina Medical Center, Chapel Hill, NC., Armistead PM; UNC Transplant and Cellular Therapy Program, University of North Carolina Medical Center, Chapel Hill, NC; Division of Hematology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Shaw JR; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC; Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; UNC Transplant and Cellular Therapy Program, University of North Carolina Medical Center, Chapel Hill, NC., Snow AE; UNC Transplant and Cellular Therapy Program, University of North Carolina Medical Center, Chapel Hill, NC; Division of Hematology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Crona DJ; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC. Electronic address: daniel.crona@unc.edu. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
